| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addition of cilostazol to aspirin therapy for secondary prevention of cardiovascular and cerebrovascular disease in patients undergoing percutaneous coronary intervention: A randomized, open-label trial
|
Ueda, Hiroshi
|
|
2016
|
173 |
C |
p. 134-142
9 p.
|
artikel
|
| 2 |
Body mass index and the risk of new-onset atrial fibrillation in middle-aged adults
|
Berkovitch, Anat
|
|
2016
|
173 |
C |
p. 41-48
8 p.
|
artikel
|
| 3 |
Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial
|
Vassalli, Giuseppe
|
|
2016
|
173 |
C |
p. 1-7
7 p.
|
artikel
|
| 4 |
Cessation treatment adherence and smoking abstinence in patients after acute myocardial infarction
|
Grandi, Sonia M.
|
|
2016
|
173 |
C |
p. 35-40
6 p.
|
artikel
|
| 5 |
Clinical benefit of high-sensitivity cardiac troponin I in the detection of exercise-induced myocardial ischemia
|
Lee, Gino
|
|
2016
|
173 |
C |
p. 8-17
10 p.
|
artikel
|
| 6 |
Clinical profiles and correlates of mortality in nonagenarians with severe aortic stenosis undergoing transcatheter aortic valve replacement
|
Escárcega, Ricardo O.
|
|
2016
|
173 |
C |
p. 118-125
8 p.
|
artikel
|
| 7 |
Coronary atherosclerosis in outlier subjects at the opposite extremes of traditional risk factors: Rationale and preliminary results of the Coronary Atherosclerosis in outlier subjects: Protective and novel Individual Risk factors Evaluation (CAPIRE) study
|
Magnoni, Marco
|
|
2016
|
173 |
C |
p. 18-26
9 p.
|
artikel
|
| 8 |
Discharge heart rate and β-blocker dose in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF registry
|
DeVore, Adam D.
|
|
2016
|
173 |
C |
p. 172-178
7 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2016
|
173 |
C |
p. A7-
1 p.
|
artikel
|
| 10 |
Incidence and characteristics of inappropriate and false-positive cardiac catheterization laboratory activations in a regional primary percutaneous coronary intervention program
|
Lu, Jonathan
|
|
2016
|
173 |
C |
p. 126-133
8 p.
|
artikel
|
| 11 |
Individualized approaches to thromboprophylaxis in atrial fibrillation
|
Ziff, Oliver J.
|
|
2016
|
173 |
C |
p. 143-158
16 p.
|
artikel
|
| 12 |
Information for Readers
|
|
|
2016
|
173 |
C |
p. A8-
1 p.
|
artikel
|
| 13 |
Longer-term impact of cardiology e-consults
|
Wasfy, Jason H.
|
|
2016
|
173 |
C |
p. 86-93
8 p.
|
artikel
|
| 14 |
Making a case for ivabradine: Should we SHIFT our focus to OPTIMIZE outcomes?
|
Cole, Robert Townsend
|
|
2016
|
173 |
C |
p. 170-171
2 p.
|
artikel
|
| 15 |
Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial
|
Acharjee, Subroto
|
|
2016
|
173 |
C |
p. 108-117
10 p.
|
artikel
|
| 16 |
Predictors and clinical outcomes of inpatient versus ambulatory management after an emergency department visit for atrial fibrillation: A population-based study
|
Tran, Christopher
|
|
2016
|
173 |
C |
p. 161-169
9 p.
|
artikel
|
| 17 |
Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation
|
Nijenhuis, Vincent Johan
|
|
2016
|
173 |
C |
p. 77-85
9 p.
|
artikel
|
| 18 |
Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
|
Sabatine, Marc S.
|
|
2016
|
173 |
C |
p. 94-101
8 p.
|
artikel
|
| 19 |
Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes
|
Vavalle, John P.
|
|
2016
|
173 |
C |
p. 57-66
10 p.
|
artikel
|
| 20 |
RenalGuard system in high-risk patients for contrast-induced acute kidney injury
|
Briguori, Carlo
|
|
2016
|
173 |
C |
p. 67-76
10 p.
|
artikel
|
| 21 |
Revisiting age-predicted maximal heart rate: Can it be used as a valid measure of effort?
|
Arena, Ross
|
|
2016
|
173 |
C |
p. 49-56
8 p.
|
artikel
|
| 22 |
Statin use, intensity, and 3-year clinical outcomes among older patients with coronary artery disease
|
O’Brien, Emily C.
|
|
2016
|
173 |
C |
p. 27-34
8 p.
|
artikel
|
| 23 |
Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial
|
Essebag, Vidal
|
|
2016
|
173 |
C |
p. 102-107
6 p.
|
artikel
|
| 24 |
Table of Contents
|
|
|
2016
|
173 |
C |
p. A4-A6
nvt p.
|
artikel
|
| 25 |
Variations in the emergency department management of atrial fibrillation: Lessons to be learned
|
McAlister, Finlay A.
|
|
2016
|
173 |
C |
p. 159-160
2 p.
|
artikel
|
Tijdschrift beschrijving